title: [Expensive new drugs requires reflection and revision: Narrow interpretation of ethical platform].
authors.affiliation: Prioriteringscentrum - Institutionen för medicin och hälsa Linköping, Sweden Prioriteringscentrum - Institutionen för medicin och hälsa Linköping, Sweden.
authors.forename: Lars
authors.initials: L
authors.lastname: Sandman
authors.forename: Per
authors.initials: P
authors.lastname: Carlsson
authors.forename: Mikael
authors.initials: M
authors.lastname: Hoffmann
authors.forename: Lars-Åke
authors.initials: LÅ
authors.lastname: Levin
authors.forename: Jan
authors.initials: J
authors.lastname: Liliemark
mesh_terms: D003362:Cost-Benefit Analysis / Q000941:ethics*; D016527:Drug Costs / Q000941:ethics*; D006801:Humans